Company Announcement Expansion of clinical program with the Lambert Initiative February 22, 2023February 22, 2023
Company Announcement Athenex takes Avecho’s Vitamin K injection to FDA pre-IND meeting January 12, 2023January 12, 2023
Company Announcement Ethics Approval received for Phase III Clinical Trial December 22, 2022December 22, 2022
Company Announcement TPM® Enhances Cannabinoid Bioavailability in Comparative Canine Study September 19, 2022September 19, 2022
Company Announcement Quarterly Activities Report and 4C to 31 March 2022 April 29, 2022April 29, 2022
Company Announcement Positive Results for Phase II Topical CBD Osteoarthritis Study March 29, 2022March 29, 2022
Company Announcement Dosing Commences for CBD Topical Osteoarthritis Study March 1, 2022March 2, 2022
